WHO ICTRP trial
A Clinical Study on the Safety and Efficacy of Gecacitinib Hydrochloride Tablets…
ChiCTR2500113178 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500113178 |
|---|---|
| Public title | A Clinical Study on the Safety and Efficacy of Gecacitinib Hydrochloride Tablets in the Treatment of Myelodysplastic Syndromes (MDS) and Myelodysplastic Syndromes/Myeloproliferative Neoplasm (MDS/MPN)Patients with Anemia. |
| Scientific title | A Clinical Study on the Safety and Efficacy of Gecacitinib Hydrochloride Tablets in the Treatment of Myelodysplastic Syndromes (MDS) and Myelodysplastic Syndromes/Myeloproliferative Neoplasm Patients with anemia. |
| Primary sponsor | Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College. |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Phase 1: MDS with anemia and low blasts complicated by myelofibrosis;MDS with anemia and increased blasts complicated by myelofibrosis. Phase 2: Lower-risk MDS with anemia. |
| Interventions | Phase 2: Lower-risk MDS group with anemia.:Gecacitinib;Phase 1, Group 2: MDS with myelofibrosis or MDS/MPN with myelofibrosis (blasts 5~19%).:Gecacitinib;Phase 1, Group 1: MDS with myelofibrosis or MDS/MPN with myelofibrosis (blasts… |
| Registration date | Nov 25, 2025 |
| Target size | Phase 2: Lower-risk MDS group with anemia.:24;Phase 1, Group 2: MDS with… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: